Opdualag Injection
Product Images NDC 0003-7125

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Opdualag (NDC 0003-7125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Opdualag-carton.jpg (Opdualag Carton)

Opdualag-carton.jpg (Opdualag Carton)
This is a description of a medication called Opdivo, which is available in a 20mL single-dose vial containing 240mg of nivolumab and 80mg of relatimab. Each mL of the vial has 12mg of ivolmab, mg of elatinab, and 1.1mg of istdie. Other ingredients include Listine hydrochioride monobyrate, pentetic acd, pobsorbat 80, sucross. It is for intravenous infusion only and is recommended to be administered through an intravenous finecontaining. The vial must be stored at 20-25°C (36°F to 46%) and protected from light until use. It is important to note that this information is not the standard of potency and that the dosage should be determined by prescription only.*
FDA Label Image

Opdualag-figure-1.jpg (Opdualag Figure 1)

Opdualag-figure-1.jpg (Opdualag Figure 1)
This is a graph representing the Probability of Progression Free Survival of two groups - OPDUALAG and Nivolumab. The graph shows the percentage of patients who were able to survive without any progression of their condition after a certain number of months. The x-axis represents time in months, while the y-axis represents the probability of survival. The group treated with Nivolumab had a higher probability of progression-free survival compared to the group treated with OPDUALAG. The number of subjects at risk in the two groups is also shown at different time points.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.